Terms: = Kidney tumors AND RECQL4, RecQ4, 9401, ENSG00000160957, RECQ4, RTS
21 results:
1. COMMD5 Inhibits Malignant Behavior of Renal Cancer Cells.
Ikeda J; Matsuda H; Ogasawara M; Ishii Y; Yamaguchi K; Takahashi S; Fukuda N; Masuhiro Y; Endo M; Soma M; Hamet P; Tremblay J
Anticancer Res; 2021 Jun; 41(6):2805-2815. PubMed ID: 34083270
[TBL] [Abstract] [Full Text] [Related]
2. Frequent breakpoints of focal deletion and uniparental disomy in 22q11.1 or 11.2 segmental duplication region reveal distinct tumorigenesis in rhabdoid tumor of the kidney.
Haruta M; Arai Y; Okita H; Tanaka Y; Takimoto T; Kamijo T; Oue T; Souzaki R; Taguchi T; Kuwahara Y; Chin M; Nakadate H; Hiyama E; Ishida Y; Koshinaga T; Kaneko Y
Genes Chromosomes Cancer; 2021 Aug; 60(8):546-558. PubMed ID: 33896058
[TBL] [Abstract] [Full Text] [Related]
3. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
[TBL] [Abstract] [Full Text] [Related]
4. SMARCB1-deficient tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract] [Full Text] [Related]
5. Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: A multi-institutional analysis.
Rodriguez Faba O; Palou J; Vila Reyes H; Guirado L; Palazzetti A; Gontero P; Vigués F; Garcia-Olaverri J; Fernández Gómez JM; Olsburg J; Terrone C; Figueiredo A; Burgos J; Lledó E; Breda A
Actas Urol Esp; 2017 Dec; 41(10):639-645. PubMed ID: 29126568
[TBL] [Abstract] [Full Text] [Related]
6. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract] [Full Text] [Related]
7. Long-term renal function in unilateral non-syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols.
Schiavetti A; Altavista P; De Luca L; Andreoli G; Megaro G; Versacci P
Pediatr Blood Cancer; 2015 Sep; 62(9):1637-44. PubMed ID: 25893525
[TBL] [Abstract] [Full Text] [Related]
8. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes.
Birks DK; Donson AM; Patel PR; Sufit A; Algar EM; Dunham C; Kleinschmidt-DeMasters BK; Handler MH; Vibhakar R; Foreman NK
Pediatr Blood Cancer; 2013 Jul; 60(7):1095-102. PubMed ID: 23382118
[TBL] [Abstract] [Full Text] [Related]
10. [Rhabdoid tumours].
Vasovčák P; Puchmajerová A; Křepelová A
Klin Onkol; 2012; 25 Suppl():S27-9. PubMed ID: 22920203
[TBL] [Abstract] [Full Text] [Related]
11. HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
Hinten F; Meeuwis KA; van Rossum MM; de Hullu JA
Crit Rev Oncol Hematol; 2012 Nov; 84(2):161-80. PubMed ID: 22425015
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines.
Huang C; Ramakrishnan R; Trkulja M; Ren X; Gabrilovich DI
Cancer Immunol Immunother; 2012 Apr; 61(4):573-9. PubMed ID: 22223258
[TBL] [Abstract] [Full Text] [Related]
13. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
[TBL] [Abstract] [Full Text] [Related]
14. The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors.
Koos B; Jeibmann A; Lünenbürger H; Mertsch S; Nupponen NN; Roselli A; Leuschner I; Paulus W; Frühwald MC; Hasselblatt M
Cancer; 2010 Nov; 116(21):5075-81. PubMed ID: 20629032
[TBL] [Abstract] [Full Text] [Related]
15. Fetal and neonatal rhabdoid tumor.
Isaacs H
J Pediatr Surg; 2010 Mar; 45(3):619-26. PubMed ID: 20223330
[TBL] [Abstract] [Full Text] [Related]
16. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.
Gadd S; Sredni ST; Huang CC; Perlman EJ;
Lab Invest; 2010 May; 90(5):724-38. PubMed ID: 20212451
[TBL] [Abstract] [Full Text] [Related]
17. Extrarenal rhabdoid tumours outside the central nervous system in infancy.
Garcés-Iñigo EF; Leung R; Sebire NJ; McHugh K
Pediatr Radiol; 2009 Aug; 39(8):817-22. PubMed ID: 19452146
[TBL] [Abstract] [Full Text] [Related]
18. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract] [Full Text] [Related]
19. Molecular genetics of atypical teratoid/rhabdoid tumor.
Biegel JA
Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
[TBL] [Abstract] [Full Text] [Related]
20. Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors.
Errasti P; Manrique J; Lavilla J; Rossich E; Hernandez A; Pujante D; Ndarabu A; García N; Purroy A
Transplant Proc; 2003 Aug; 35(5):1717-9. PubMed ID: 12962769
[TBL] [Abstract] [Full Text] [Related]
[Next]
